KEMRI has strengthened its position as a leader in health research and innovation following the successful launch of the Accelerating Clinical Trials for CHIKungunya Vaccine in Africa (ACT-CHIK) project..
KEMRI has officially joined the inaugural Excell Malaria Programme, a new collaboration with the AREF)aimed at strengthening malaria research capacity and developing the next generation of African scientific leaders...